Correlations between F-18 FDG PET/CT and pathological findings in soft tissue lesions

Journal of Medical Investigation

Volumn 60, Issue 3-4, 2013, Pages 184-190

  Nose, Hayato ^a   Otsuka, Hideki ^a   Otomi, Yoichi ^a   Terazawa, Kaori ^a   Takao, Shoichiro ^a   Iwamoto, Seiji ^a   Harada, Masafumi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

F 18 FDG PET; Liposarcoma; Myxoid tumor; Neurogenic tumor; Soft tissue tumor

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE MEGLUMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATYPICAL FIBROXANTHOMA; CARCINOMA; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DESMOID TUMOR; EWING SARCOMA; FEMALE; GRANULOMA; HEMANGIOMA; HEMATOMA; HUMAN; LARGE CELL LYMPHOMA; LIPOSARCOMA; MALE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; METASTASIS; MYXOFIBROSARCOMA; MYXOID CHONDROSARCOMA; MYXOSARCOMA; NEURILEMOMA; NEUROFIBROMA; NEUROGENIC TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OSSIFYING MYOSITIS; PET SCANNER; SARCOMA; SENSITIVITY AND SPECIFICITY; SOFT TISSUE CANCER; SOFT TISSUE DISEASE; SOFT TISSUE TUMOR; SYNOVIAL SARCOMA; XANTHOGRANULOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIPOSARCOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURILEMMOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84887005740     PISSN: 13431420     EISSN: 13496867     Source Type: Journal    
DOI: 10.2152/jmi.60.184     Document Type: Article

References (22)

1. Schuetze SM, Rubin BP, Vernon C, Hawkins DS, Bruckner JD, Conrad EU 3rd: Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 103(2): 339-348, 2005
2. Ghigi G, Micera R, Maffione AM, Castellucci P, Cammelli S, Ammendolia I, Nanni C, Barbieri E, Grassetto G, Fanti S, Rubello D: 11C methionine vs. 18F-FDG PET in soft tissue sarcoma patients treated with neoadjuvant therapy: preliminary results. In Vivo 23(1): 105-110, 2009
3. Yamamoto Y, Kawaguchi Y, Kawase Y, Maeda Y, Nishiyama Y: A comparative study of F-18 FDG PET and 201Tl scintigraphy for detection of primary malignant bone and soft-tissue tumors. Clin Nucl Med 36(4): 290-294, 2011
4. Shin DS, Shon OJ, Han DS, Choi JH, Chun KA, Cho IH: The clinical efficacy of (18)F-FDGPET/CT in benign and malignant musculoskeletal tumors. Ann Nucl Med 22(7): 603-609, 2008
5. Charest M, Hickeson M, Lisbona R, Novales Diaz JA, Derbekyan V, Turcotte RE: FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases. Eur J Nucl Med Mol Imaging 36(12): 1944-1951, 2009
6. Iagaru A, Quon A, McDougall IR, Gambhir SS: F-18FDGPET/CTevaluationofosseousand soft tissue sarcomas. Clin Nucl Med 31(12): 754-760, 2006
7. 18F]fluorodeocyglucose positron emission tomography. Eur J Nucl Med Mol Imaging 33(6): 683-690, 2006
8. John PA, Ioannidis JL: 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med 44(5): 717-724, 2003
9. Suzuki R, Watanabe H, Yanagawa T, Sato J, Shinozaki T, Suzuki H: PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma. Ann Nucl Med 19(8): 661-670, 2005
10. Benz MR, Czernin JC, Dry SM, Tap WD, Allen Auerbach MS, Elashoff D, Phelps ME, Weber WA, Eilber FC: Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 116(2): 451-458, 2010
11. Conill C, Setoain X, Colomo L, Palacín A, Combalia-Aleu A, Pomés J, Marruecos J, Vargas M, Maurel J: Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma. J Magn Reson Imaging 27: 625-628, 2008
12. Schwab JH, Healey JH: FDG-PET lacks sufficient sensitivity to detect myxoid liposarcoma spinal metastases detected by MRI. Sarcoma 2007; 2007: 36785. doi: 10.1155/2007/36785
13. Sheah K, Ouellette HA, Torriani M, Nielsen GP, Kattapuram S, Bredella MA: Metastatic myxoid liposarcomas: imaging and histopathologic findings. Skeletal Radiol 37(3): 251-258, 2008
14. Schwarzbach MH, Dimitrakopoulou-Strauss A, Mechtersheimer G, Hinz U, Willeke F, Cardona S, Attigah N, Strauss LG, Herfarth C, Lehnert T: Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET). Anticancer Res 21(5): 3609-3614, 2001
15. Enomoto K, Inohara H, Hamada K, Tamura M, Tomita Y, Kubo T, Hatazawa J: FDG PET Imaging of myxofibrosarcoma on the sphenoid sinus. Clin Nucl Med 33(6): 421-422, 2008
16. Beaulieu S, Rubin B, Djang D, Conrad E, Turcotte E, Eary JF: Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning. AJR Am J Roentgenol 182: 971-974, 2004
17. Ahmed AR, Watanabe H, Aoki J, Shinozaki T, Takagishi K: Schwannoma of the extremities: the role of PET in preoperative planning. Eur J Nucl Med 10: 1541-1551, 2001
18. Otsuka H, Graham MM, Kubo A, Nishitani H: FDG-PET/CT finding of sarcomatous transformation in neurofibromatosis: a case report. Ann Nucl Med 19(1): 55-58, 2005
19. Ferner RE, Golding JF, Smith M, Calonje E, Jan W, Sanjayanathan V, O'Doherty M: [18F] 2-fluoro-2-deoxy-D-glucosepositronemission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol 19: 390-394, 2008
20. De Waele M, Carp L, Lauwers P, Hendriks J, De Maeseneer M, Van Schil P, Blockx P: Paravertebral schwannoma with high uptake of fluorodeoxyglucose on positron emission tomography. Acta Chir Belg 105(5): 537-538, 2005
21. Porter DE, Prasad V, Foster L, Dall GF, Birch R, Grimer RJ: Survival in malignant peripheral nerve sheath tumours: a comparison between sporadic and neurofibromatosis type 1-associated tumours. Sarcoma 2009; 2009: 756395. doi: 10.1155/2009/756395
22. 18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 36: 751-757, 2009